Skip to main
ASPI
ASPI logo

ASPI Stock Forecast & Price Target

ASPI Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

ASP Isotopes Inc. is focused on utilizing its advanced laser-based quantum enrichment technology to validate and enhance its capabilities in isotope production, particularly with ytterbium-176, which lays the groundwork for future uranium-235 enrichment. This successful application not only reinforces confidence in the company's technology but also positions ASP Isotopes to capitalize on opportunities in the advanced nuclear fuel market through high-assay low-enriched uranium (HALEU). Additionally, the competitive pricing and potential for lower production costs associated with their energy resources in South Africa contribute to a positive financial outlook for the company as it moves toward commercialization.

Bears say

ASP Isotopes Inc. faces significant challenges that adversely affect its financial outlook, primarily stemming from delays that have hindered cash flow, ultimately limiting operational progress. Additionally, the company is impacted by systemic issues, including a vulnerable power grid and outdated facilities, which have caused ongoing electricity shortages and operational inefficiencies since 2007. Furthermore, the rising demand and costs for natural gas, driven by a rapidly depleting supply through the ROMPCO pipeline, exacerbate the operational and financial pressures on the company.

ASPI has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of ASP Isotopes Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About ASP Isotopes Inc (ASPI) Forecast

Analysts have given ASPI a Strong Buy based on their latest research and market trends.

According to 1 analysts, ASPI has a Strong Buy consensus rating as of Nov 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $11, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $11, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

ASP Isotopes Inc (ASPI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.